Shares of Legend Biotech (NASDAQ:LEGN | LEGN Price Prediction) are climbing 6% to $21.88 Tuesday mid

Legend Biotech NASDAQ: LEGN reported second-quarter 2026 results marked by continued global growth f

The most oversold health care stocks present a buying opportunity. RSI indicator compares stock stre

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a

Legend Biotech Corporation Sponsored ADR (NASDAQ: LEGN - Get Free Report)'s share price gapped down

RBC Capital analyst Leonid Timashev maintains Legend Biotech (NASDAQ:LEGN) with a Outperform and

Legend Biotech Corporation (NASDAQ:LEGN) ("Legend Biotech" or the "Company"), a glob

BRIDGEWATER, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Leg

On July 15, J&J, a Legend Biotech Corporation partner, announced continued strong demand for Carvykt

UBS analyst Ashwani Verma downgrades Legend Biotech (NASDAQ:LEGN) from Buy to Neutral and lowers

Health care sector oversold - buying opportunities in undervalued companies. RSI compares stock stre

JP Morgan analyst Jessica Fye reinstates Legend Biotech (NASDAQ:LEGN) with a Neutral and announce

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 1% on Thursday.

US stock futures up, Nasdaq futures 1% higher. Legend Biotech (LEGN) priced 7.7 million ADSs at $29.

Smith & Wesson (SWBI) shares rose in pre-market trading after posting strong Q4 results, beating

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Leg

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Leg

Achieved 100% ORR and 83.3% CR rate at dose level 2 following a single infusion in patients with rel

BRIDGEWATER, N.J., June 14, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Lege

Top Wall Street analysts changed outlook on top names. For all rating changes, upgrades and downgrad

Legend Biotech (LEGN) remains a buy as Carvykti's earlier-line use drives superior efficacy, safety,

Legend Biotech's experimental therapy showed early signs that its approach of generating disease-fig

BRIDGEWATER, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Lege

BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) --  Legend Biotech Corporation (NASDAQ: LEGN) (Leg

Legend Biotech Corporation (LEGN) Shareholder/Analyst Call Transcript

Legend Biotech NASDAQ: LEGN used an investor and analyst event to highlight long-term data and physi

SOMERSET, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend B

Legend Biotech develops cell therapies for cancer, with a pipeline spanning hematologic malignancies

Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers f

Legend Biotech Corp (NASDAQ:LEGN) reported downbeat results for the first quarter on Tuesday.

Legend Biotech Corporation (LEGN) Q1 2026 Earnings Call Transcript

Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainer

Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report qu

Companies Reporting Before The Bell • Mainz Biomed (NASDAQ:MYNZ) is projected to report earnings fo

Upgrades

Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday aft